Gainers
Biophytis (NASDAQ:BPTS) stock moved upwards by 15.8% to $0.95 during Monday's after-market session. The company's market cap stands at $15.5 million.
Checkpoint Therapeutics, Inc. (Checkpoint) (NASDAQ:CKPT), a clinical-stage immunotherapy and targeted oncology company, today announced that it has received Pediatric Investigation Plan (PIP) product-specific waivers
Checkpoint Therapeutics (NASDAQ:CKPT) brought in sales totaling $16.00 thousand during Q4 according to data provided by Benzinga Pro. However, earnings decreased 164.15%, resulting in a loss of $29.76 million.